Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

27

Revenue 2017

Gilenya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gilenya was produced by Novartis.

Merck KGaA drops Ono-partnered multiple sclerosis drug

Merck KGaA drops Ono-partnered multiple sclerosis drug Like other interferon drugs, Rebif is facing growing competition from a new generation of orally-active MS drugs such as Biogen Idec's Tecfidera (dimethyl fumarate) and Novartis' S1P agonist Gilenya

Back to the future

Back to the future The successes of Gilenya, Afinitor/Votubia, Galvus, Tasigna and Jakavi - as well as its generics arm, Sandoz - mean that Novartis is now less than $500m behind Pfizer in second place.

Teva backs laquinimod for MS despite CHMP rejection

Teva backs laquinimod for MS despite CHMP rejection as Biogen Idec's fast-growing Tecfidera (dimethyl fumarate) and Novartis' Gilenya (fingolimod).

New Novartis MS app will turn up the heat on its rivals

New Novartis MS app will turn up the heat on its rivals If the app gains sufficient traction among patients it will also provide healthcare professionals with real world evidence on how well particular treatments - such as Novartis' own Gilenya (fingolimod), for example -

Bayer’s Nexavar recommended for thyroid cancer in EU

Bayer’s Nexavar recommended for thyroid cancer in EU Elsewhere, Janssen's antipsychotic Invega (paliperidone) was backed to expand its use to include schizophrenia patients as young as 15 and the CHMP recommended revised indications for Novartis' Gilenya (fingolimod) and

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics